Common trend: move to enucleation—Is there a case for GreenLight enucleation? Development and description of the technique by Fernando Gomez Sancha et al.
1 3
World J Urol (2015) 33:539–547
DOI 10.1007/s00345-014-1339-9
TOPIC PAPER
Common trend: move to enucleation—Is there a case 
for GreenLight enucleation? Development and description of the 
technique
Fernando Gomez Sancha · Vanesa Cuadros Rivera · 
Georgi Georgiev · Alexander Botsevski · Julian Kotsev · 
Thomas Herrmann 
Received: 6 April 2014 / Accepted: 2 June 2014 / Published online: 15 June 2014 
© The Author(s) 2014. This article is published with open access at Springerlink.com
transitional zone is excised in a single bloc and morcellated 
after its placement into the bladder.
Conclusion  This new GreenLight en bloc enucleation 
technique allows to treat larger prostates than those previ-
ously treated with the PVP technique.
Keywords GreenLight laser · Benign prostatic 
enlargement · Enucleation · Vaporization
Abbreviations
EAU  European Association of Urology
PVP  Photoselective vaporization of the prostate
TRUS  Transrectal ultrasound of the prostate
HoLAP  Holmium laser ablation of the prostate
HoLRP  Holmium laser resection of the prostate
Ho:YAG  Holmium:yttrium–aluminum–garnet
Tm:YAG  Thulium:yttrium–aluminum–garnet
Tm:VARP  Thulium laser prostate vaporesection
ThuVEP  Thulium:YAG laser vapoenucleation
ThuLEP  Thulium laser enucleation
Introduction
Since the renaissance of lasers in the treatment of benign 
prostatic obstruction (BPO) secondary to benign prostate 
enlargement (BPE) after the neodymium: yttrium–alu-
minum–garnet (Nd:YAG) era, laser prostatectomy has been 
employed for almost two decades with beneficial results. 
A range of laser has been employed involving different 
wavelengths, power capacities, and modes of action. The 
current European Association of Urology (EAU) guide-
lines on non-neurogenic male lower urinary tract symptoms 
(LUTS) recommend both holmium:YAG (Ho:YAG) laser 
enucleation (HoLEP) and photoselective vaporization of 
Abstract 
Background Transurethral laser prostatectomy has 
evolved as a viable alternative for the management of 
benign prostate enlargement. Since the renaissance of laser 
prostatectomy with the advent of the holmium:yttrium–alu-
minum–garnet laser in the 1990s, various lasers and subse-
quent procedures have been introduced. These techniques 
can be categorized as vaporizing, resecting, and enucleat-
ing approaches. Photoselective vaporization of the prostate 
(PVP) is dominated by high-power lithium triborate (LBO) 
crystal lasers (GreenLight XPS). The mainstay of this tech-
nique is for the treatment of small to medium prostate vol-
umes whereas enucleating techniques, such as holmium 
laser enucleation of the prostate and thulium enucleation 
of the prostate, focus on large-volume glands. In order to 
perspectively “delimit” LBO into the field of large-volume 
prostates, we developed LBO en bloc enucleation to render 
it as a competing transurethral enucleating approach.
Materials and methods We present a detailed stepwise 
progressive technique developed in Madrid, Spain, for the 
complete removal of the transitional zone by vapoenuclea-
tion. The steps include exposition of the prostatic capsule 
by PVP toward the peripheral zone, thereby identifying 
the anatomical limits of enucleation. Subsequently, the 
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the prostate (PVP; GreenLight) as minimally invasive alter-
natives to transurethral resection of the prostate (TURP) 
in men with LUTS secondary to BPO [1]. The American 
Association of Urology guidelines state that, furthermore, 
all holmium-based techniques [such as HoLEP, holmium 
laser resection of the prostate (HoLRP), and holmium 
laser ablation of the prostate (HoLAP)] as well as PVP are 
appropriate and effective treatment alternatives to TURP 
[2]. This is supported by the EAU guidelines on lasers 
and technologies also evaluating thulium-based resection/
enucleation techniques [thulium:yttrium–aluminum–gar-
net (Tm:YAG) laser prostate vaporesection (ThuVARP), 
thulium:YAG laser vapoenucleation (ThuVEP), and thu-
lium laser enucleation (ThuLEP)] [3].
GreenLight-based PVP evolved from potassium-titanyl 
phosphate (KTP) 532 nm laser to 120 W LBO (GreenLight 
HPS) and the current 180 W LBO XPS laser system involv-
ing the MoXy Liquid Cooled side-firing fiber. PVP ablates 
tissue by vaporization of tissue from the prostatic urethra 
toward the prostatic capsule (inside-out), whereas laser 
energy in enucleating techniques such as HoLEP or Thu-
VEP [4], ThuLEP [5], and diode laser-based enucleations 
(eraser enucleation [6]/diode laser enucleation [7] ) is used 
to enter the plane of the prostatic capsule and dissect and 
detach the prostatic lobes (outside-in).
A meta-analysis published in 2012 revealed that equiva-
lent clinical outcome was achieved with the GreenLight 
laser and TURP but with reduced likelihood of blood trans-
fusion and clot retention with the laser treatment [8]. Sur-
gical time was longer with the laser treatment than TURP. 
The most recent report comes from the GOLIATH Study 
in which 281 men with LUTS due BPO were randomized 
to treatment with the GreenLight laser with the 180 W GL 
XPS laser or TURP [9]. Results from the study showed that 
the two treatments were comparable in terms of improve-
ment in symptoms, maximum flow rate, postvoid residual 
urine (PVR), and complications. Hospital stay and dura-
tion of catheterization were shorter with the GreenLight 
laser than TURP, and early reintervention (up to 30 days) 
was three times higher in the TURP group. These studies 
involved men with prostates sized <80 ml. One randomized 
controlled trial evaluated prostates sized >80 ml treated 
with open prostatectomy or laser therapy [10]. Results 
showed comparable safety and efficacy outcome between 
the two treatments.
Development of an enucleation technique with the 
GreenLight laser
The inherent problem of extra-anatomical approaches, such 
as resection or vaporization of the adenoma, is the dif-
ficulty in determining the anatomical cleavage limits, i.e., 
where to stop the vaporization and to understand when the 
prostate capsule has been reached. Attempts to vaporize 
the adenoma aggressively can lead to capsular violation or 
perforation and residual adenomatous tissue can remain, 
which might require retreatment or promote late secondary 
bleeding (Fig. 1). One of the limitations of PVP is the chal-
lenge encountered in large-volume prostates (>90 ml) in 
completely vaporizing the transitional zone. Hueber et al. 
[11] report that although prostates sized >100 ml can be 
treated with PVP, operating times are longer and retreat-
ment rates can be as high as 9 %. GreenLight laser enuclea-
tion has been developed by Dr Fernando Gomez Sancha in 
Spain and Bulgaria to overcome these problems and has 
involved logical steps from standard vaporization to ana-




A 532-nm lithium triborate laser (GreenLight HPS 120 W 
and GreenLight XPS 180 W surgical lasers, American 
Medical Systems, Minnetonka, US) was used. Two differ-
ent fibers were employed: the 2090 fiber and the MoXy 
fiber. The en bloc enucleation technique was preferably 
carried out with the 2090 fiber at power settings of 80 W 
for cutting and 40 W for coagulation. The MoXy fiber 
was used at a power setting of 180 W power for vaporiza-
tion and of 40 W power for coagulation. The 2090 fiber 
was better for enucleation as the procedure needs lower 
power, and it was more resilient and resistant to contact 
Fig. 1  Capsule perforation or invasion caused by overaggressive 
vaporization. Insufficient vaporization can leave prostate tissue in 
place
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vaporization, which was sometimes necessary during the 
enucleation technique. Also, the back of the fiber could be 
used to coagulate. Both anatomic vaporization and vapoe-
nucleation require a big deal of vaporizing, and the MoXy 
fiber at 180 W power provided fast vaporization, and it 
also allowed for partial enucleation, when the power was 
reduced to 120 W. However, this fiber was less resist-
ant to mechanical trauma and manipulation and could 
experience breakages when used for enucleation (Figs. 2, 
3, 4, 5).
Endoscopy equipment
A 26-F continuous flow resectoscope (Richard Wolf, Ger-
many) with a special laser bridge for the laser fiber was 
used; a 30° down lens was preferred. It is important to use 
Fig. 2  Anatomic photoselec-
tive vaporization (PVP). The 
starting point of this technique 
is a standard PVP central cavity 
(1). The capsular localization 
maneuver is performed in both 
sides using the tip of the scope 
and joined in the midline (2, 3). 
Careful mechanical dissec-
tion is carried out toward the 
bladder neck at 6 o’clock, and 
a full incision of the adenoma-
tous tissue down to capsule is 
completed (4, 5). Vaporization 
is carried out laterally and ante-
riorly following the capsular 
plane (6)
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a resectoscope with a traumatic flat end or a smooth edge 
in order to avoid capsular perforation when the mechani-
cal dissection was carried out with the shaft of the resec-
toscope. A straight laparoscopic camera (Richard Wolf, 
Germany) was connected to the telescope for image 
enlargement and recording of procedures. Saline solution 
was used for irrigation throughout the procedure, keeping 
the height of the bags at 40–60 cm except for the morcel-
lation phase (80–100 cm for distension of the bladder at 
physiological intravesical pressure).
Morcellator
A mechanical tissue morcellator (Piranha: Richard Wolf 
GMbH, Knittlingen, Germany) was used for intravesical 
morcellation of fragments. The new disposable Vmax sin-
gle use rotation blades (Richard Wolf GMbH, Germany) 
were used in conjunction with the motor, control unit, foot 
pedal, and suction pump. A morcelloscope/nephroscope 
was adapted to the external sheath of the resectoscope in 
order to allow introduction of the morcellator blade into the 
26-F continuous flow resectoscope (Richard Wolf GMbH, 
Germany). A double inflow and higher saline bag height 
was preferable to keep the bladder distended so that blad-
der wall injuries were avoided during morcellation.
Surgical technique
Three stages of surgical technique are described, which 
represent the stepwise learning process.
Patient preparation
The patient is placed in the lithotomy position as for a 
TURP. After sterilization of the skin and surgical draping, 
sterile anesthetic gel is instilled into the urethra. Dilatation 
or Otis urethrotomy is performed if needed. Under direct 
vision, a 26-F continuous flow resectoscope is inserted in 
the urethra avoiding urethral or prostatic trauma and bleed-
ing that can make the procedure more difficult to perform. 
A straight laparoscopic camera is preferred in order to 
avoid interference with the laser fiber. The outflow must 
always be opened to avoid bladder overdistension. Keep-
ing the irrigation fluid bags low lowers the pressure in the 
operative field and promotes better intraoperative hemosta-
sis and it also lowers the risk of fluid absorption. To keep 
the bladder distended, the bags must be elevated for the 
morcellation phase. A careful cystoscopy is carried out to 
rule out bladder problems and to visualize the ureteral ori-
fices. The anatomy of the sphincter and prostatic urethra is 
visualized as it is important for surgical planning.
Fig. 3  Photoselective vapoenucleation. A standard vaporization cav-
ity is performed leaving the middle lobe intact (1–3). The capsule is 
localized lateral to veru montanum on both sides, and mechanical dis-
section of the plane is carried out toward the bladder neck at 5 and 7 
o’clock (4, 5). The middle lobe is dissected with the tip of the scope, 
and the attachments at 6 o`clock are cut to release it into bladder for 
subsequent morcellation (6). Vaporization of remaining lateral and 
anterior tissue is carried out following the capsular plane (7, 8)
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Stage 1: Anatomic photoselective vaporization
To improve standard photoselective vaporization of the 
prostate (PVP), the depth of vaporization is based on the 
anatomical localization of the capsule. This “anatomical 
PVP” performs a central cavity in the prostate with the 
standard technique for vaporization as described previously 
[12]. The next step is to localize the capsule at the apex of 
the adenoma by carrying out a bilateral incision lateral to 
the veru montanum and then using the tip of the shaft/beak 
of the resectoscope to push laterally and find and develop 
the interphase between capsule and adenoma. This capsular 
Fig. 4  Photoselective en bloc enucleation. The procedure starts at the 
apex marking the “white line” demarcating the limit of the external 
sphincter (1). The sphincter is progressively dissected off the apex of 
the prostate from 6 toward 12 o’clock on one side (3, 4). Mechanical 
dissection of the plane between capsule and lateral lobe is performed, 
alternating with hemostasis (5–7). The bladder is entered anteriorly 
and cut toward 7 and 12 o’clock (8). A similar process is carried out 
on the contralateral side, and then, the crista urethralis is cut and the 
posterior aspect developed with mechanical dissection until the ade-
noma can be flipped into the bladder (9). The remaining attachment at 
6 o’clock is cut to release it into the bladder and morcellation follows 
(10)
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localization maneuver is paramount for the later develop-
ment of GreenLight laser en bloc enucleation. Hemostasis 
of bleeding vessels is carried out during the procedure. 
As both lateral planes are exposed, these planes are con-
nected medially proximal to the veru montanum. Careful 
mechanical dissection of the plane with the resectoscope 
is followed toward the bladder neck at 6 o’clock, alternat-
ing with low-power coagulation of any capsular bleeding. 
A 6 o’clock incision is made by firing the laser upwards 
from below the adenoma to vaporize adenomatous tissue. 
This allows visualization of the capsule from the veru mon-
tanum to the bladder neck and will serve as the anatomic 
reference of the capsule for the remainder of the procedure. 
Vaporization is then carried out laterally in both sides and 
anteriorly with the knowledge of the precise depth of the 
capsule. Intraoperative transrectal ultrasound is conducted 
to check that all the adenomatous tissue has been removed.
Stage 2: Photoselective vapoenucleation
The vapoenucleation hybrid technique allows the surgeon 
to familiarize himself with the capsular anatomy and with 
the mechanical dissection maneuvers that need to be carried 
out for the development of the anatomical plane between 
adenoma and capsule. A standard vaporization technique 
is carried out leaving the median lobe intact. Five and 7 
o’clock incisions are carried out without attempting to reach 
the surgical capsule. The capsular localization maneuver is 
performed and instead of dissecting the plane at 6 o’clock, 
the dissection follows the direction of the previous incisions, 
toward 5 and 7 o’clock. The remaining adenomatous tissue 
is vaporized to create two grooves at 5 and 7 o’clock that 
reach the surgical capsule. Then, the median lobe is dissected 
mechanically and flipped into the bladder. If the median lobe 
is left attached at 6 o’clock, it can be resected with bipolar 
or monopolar TURP bloodlessly, or if it is released into the 
bladder, it can be morcellated. This small-volume morcella-
tion is usually carried out in outstanding visibility conditions 
and serves well as a learning curve for morcellation.
Stage 3: Photoselective en bloc enucleation
A circumferential incision is carried out to mark the 
limit between the apex of the adenoma and the external 
Fig. 5  Pre- and postoperative transrectal ultrasound of the prostate showing the excellent removal of the adenoma
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sphincter, respecting the veru montanum. The crista ure-
thralis is not cut. This “white line” will serve as a landmark 
for sphincter preservation throughout the procedure. The 
capsular localization maneuver is carried out on the right 
side, and mechanical enucleation is carried out using the tip 
of the scope to develop the virtual space between surgical 
capsule and adenoma, alternating gentle dissection maneu-
vers with coagulation at low power of any capsular bleed-
ing. Of note, the recognition of the capsular plane is easier 
than with holmium laser as the capsule is not affected by 
mechanical pulse energy, and thus, the anatomy is more 
recognizable. Progressively, the apex is carefully liberated 
from the sphincter by cutting at 80 W power. The dissec-
tion is aimed ventrally and the bladder is spontaneously 
entered at 11 o’clock just by following the anatomical 
plane between capsule and adenoma. Then, the bladder 
neck is incised toward 12 and 7 o`clock. Once the right side 
is released completely from the capsule, the same steps 
are carried out on the other side. When all lateral and ante-
rior aspects of the adenoma are free, the cresta urethralis 
is cut at 6 o’clock and the posterior aspect is liberated. It 
then becomes possible to flip the adenoma into the bladder 
by lifting it and pushing it carefully with the scope. The 6 
o’clock attachment at the bladder neck is cut to deliver the 
adenoma “en bloc” into the bladder. Morcellation is car-
ried out to finish the procedure. The urinary catheter can be 
removed the morning after all these surgical variants.
Discussion
The possibility of using the GreenLight laser in an enu-
cleating approach was first discussed in 2010. The pro-
cedure consisted of an initial vaporization of the anterior 
zone, particularly the para-sphincteric areas at 11, 12, and 
1 o’clock in order to simplify the subsequent enucleative 
procedure [13]. The technique of GreenLight laser photose-
lective vapoenucleation described in the current manuscript 
involves a gradual learning path. Surgeons can start by just 
localizing the capsule for anatomic vaporization, then mov-
ing on to perform partial enucleations, and then, when they 
have developed the necessary skills and have sound ana-
tomical knowledge, they can perform the whole en bloc 
enucleation procedure. Also interestingly, they are trained 
to perform morcellation of tissue with small pieces at first, 
with very good visualization conditions and then move on 
to more complex cases. One of the potential advantages of 
using a GreenLight enucleation procedure is that it allows 
the surgeon to switch between resection and vaporization at 
any time during the procedure if needed during the learning 
curve.
Brunken et al. [14] reported a feasibility study on Green-
Light laser enucleation involving 21 men with mean (SD) 
prostate size 75 (38) ml. The technique employed enucle-
ating the median lobe of the prostate using vaporization 
of deep channels at the 5 and 7 o’clock positions from the 
bladder neck to the veru montanum down to the surgical 
capsule and then connecting the channels. The excised tis-
sue was dissected toward the bladder neck. Vaporization 
of tissue lateral to the veru montanum down to the cap-
sule followed. The lateral lobes were then dissected and 
tissue removed with a morcellator. The mean (SD) opera-
tive time was 112 (27) min, and intraoperatively, there 
was one capsule perforation. Catheterization time was 1.2 
(0.4) days and hospitalization was 3.6 (0.9) days. The pro-
cedure allowed the removal of 35 (220) g prostate tissue, 
which was equivalent to 47 % of the total prostate weight. 
Improvements in symptom score and PVR were reported at 
the mean (SD) follow-up of 5.8 (1.8) months.
Since 1998, transurethral enucleation is performed using 
a Ho:YAG laser, which operates at 2,140 nm in a pulsed 
manner and can be used to enucleate (HoLEP) or resect 
(HoLRP) the prostate. The wavelength employed by the 
laser is strongly absorbed by water, and for this reason, the 
area of tissue coagulation that results is limited to 3–4 mm, 
which reduces blood loss [15]. In terms of efficacy, a num-
ber of studies have been published providing long-term 
outcome data up to a mean of 6.1 years revealing durable 
outcome [16]. A randomized controlled trial comparing 
transurethral resection of the prostate with HoLRP has indi-
cated comparable symptomatic and urodynamic improve-
ments, but a significantly longer mean resection time 
with the laser treatment (42.1 vs. 25.8 min) [17]. Results 
from two meta-analyses show comparable symptomatic 
improvement with TURP and HoLEP but longer operat-
ing time with laser therapy [18, 19]. In terms of safety of 
this laser, no critical complications have been reported. 
Peri-operative dysuria rates of around 10 % have been pub-
lished [5, 15, 20]. Post-operative complications include 
retrograde ejaculation (75–80 %) [15]. Early postoperative 
urinary incontinence rates reported range from 8.3 % to 
44 % [21–23]. The meta-analyses revealed a significantly 
shorter catheterization time and hospital stay with HoLEP 
than TURP as well as reduced blood loss and fewer blood 
transfusions, but a longer operation time [18, 19]. One of 
the perceived limitation to the use of the holmium laser is 
the need for specialist endoscopic skills and a long learning 
curve.
The thulium:yttrium–aluminum–garnet (Tm:YAG) 
laser can be used in four different modes: vaporiza-
tion (ThuVAP), vaporesection (ThuVARP), vapoenu-
cleation (ThuVEP), or enucleation (ThuLEP). Mattioli 
et al. [24] reported good outcome when the laser operat-
ing at 70 W power in a vaporization technique was used 
to treat 99 patients with prostates sized <35 ml. Sympto-
matic improvement out to 9 months and reduced PVR were 
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reported. The majority of the data on the Tm:YAG laser 
focus on its use in a resecting mode. In common with the 
Ho:YAG laser, the Tm:YAG laser has a shallow penetration 
and excellent hemostasis. Operating in a 2 µm continuous 
wave mode causes increased vaporization capacity, result-
ing in resection combined with tissue vaporization [25, 26]. 
Vaporesection with the Tm:YAG laser has been compared 
in a randomized controlled trial with TURP and shown to 
produce comparable clinical outcome but with reduced 
morbidity, in particular, reduced bleeding and shorter hos-
pitalization and catheterizations times [26]. ThuVEP has 
been compared with the HoLEP and shown to have com-
parable short-term results with reduced blood loss with the 
ThuVEP technique [4]. Gross et al. [5] have also reviewed 
outcome in 1,080 patients treated with ThuVEP at a sin-
gle institution and found the procedure to be effective and 
safe. A more recent modification of the technique involves 
ThuLEP, in which the laser is used to incise the prostate tis-
sue to the level of the capsule and enucleate prostate lobes 
that are later morcellated [27].
Enucleation with the GreenLight laser has some differ-
ences to HoLEP and ThuLEP. GreenLight uses a 70° angle 
side-firing fiber, while the holmium and thulium lasers 
employ an end-firing fiber. HoLEP and ThuLEP enucleate 
the adenoma in two or three pieces in contrast to Green-
Light laser en bloc enucleation, which enucleates the pros-
tate in one piece. The main advantage of mechanical enu-
cleation with the GreenLight laser is that the anatomy is 
not altered at all by the effect of energy on tissue. Coagu-
lation of the capsule at 40 W is performed after the plane 
has been dissected, and this helps in the recognition of the 
right plane for enucleation. Also, the amount of energy the 
surgical capsule receives is relatively low, and this might 
result in a reduced likelihood of postoperative dysuria. 
Another potential advantage is that gentle mechanical dis-
section keeps the surgical plane in the interphase, reduc-
ing the chance of capsular invasion or perforation and 
minimizing the occurrence of sinus opening and saline 
absorption.
Conclusion
The GreenLight laser has demonstrated excellent vapori-
zation and coagulation properties in prostatic tissue. The 
standard vaporization technique has some limitations in 
terms of gland size that can be treated. The techniques 
described in this paper allow the surgeon to learn how to 
perform complete removal of larger prostate glands in 
a stepwise fashion, allowing for a progressive learning 
curve until he/she can perform en bloc enucleation and 
morcellation.
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